06/09/2026 | Press release | Distributed by Public on 06/09/2026 15:15
Item 5.07 Submission of Matters to a Vote of Security Holders.
On June 9, 2026, Avalon GloboCare Corp. (the "Company") held its annual meeting of stockholders (the "Annual Meeting") for the purpose of holding a stockholder vote on Proposals 1, 2, 3, 4, 5, and 6 set forth below. A total of 4,364,690 shares of the Company's common stock, constituting a quorum, were represented in person or by valid proxies at the Annual Meeting.
At the Annual Meeting, the Company's stockholders:
| 1. | Elected four (4) members of the Company's board of directors (the "Board") to serve for a one-year term to expire at the 2027 annual meeting of stockholders; |
| 2. | Ratified the appointment of M&K CPAS, PLLC ("M&K") as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026; |
| 3. | Approved the Avalon GloboCare Corp. 2026 Stock Incentive Plan (the "2026 Plan Proposal"); |
| 4. | Approved, on an advisory basis, the 2025 compensation of our named executive officer (the "Say-on-Pay Proposal"); |
| 5. | Approved, for the purposes of complying with Nasdaq Listing Rule 5635(d), (i) the issuance of Series A-1 warrants to purchase up to 6,372,550 shares of common stock (the "Series A-1 Warrants"), (ii) the issuance of Series A-2 warrants to purchase up to 6,372,550 shares of common stock (the "Series A-2 Warrants" and together with the Series A-1 Warrants, the "Warrants"), (iii) the issuance of warrants (the "Placement Agent Warrants") to purchase up to 318,628 shares of common stock issued to H.C. Wainwright & Co., LLC (the "Placement Agent") and (iv) the shares of common stock issuable upon the exercise of the Warrants and the Placement Agent Warrants all issued in connection with our private placement that closed on February 27, 2026 (the "February 2026 Warrant Issuance Proposal"); and |
| 6. | Approved a proposal to give the Board the authority, at its discretion, to file a certificate of amendment to the Company's amended and restated certificate of incorporation, as amended ("Certificate of Incorporation"), to effect a reverse split of the Company's issued common stock at a ratio that is not less than 1-for-2 and not greater than 1-for-25, without reducing the authorized number of shares of the Company's common stock, with the exact ratio to be selected by the Board in its discretion and to be effected, if at all, in the sole discretion of the Board at any time following stockholder approval of the amendment to the Company's Certificate of Incorporation and before June 9, 2027 without further approval or authorization of the stockholders (the "Reverse Stock Split Proposal"). |
The final results for each of the matters submitted to a vote of shareholders at the Annual Meeting, as set forth in the Company's Definitive Proxy Statement, filed with the Securities and Exchange Commission on April 17, 2026, are as follows:
Proposal 1. At the Annual Meeting, the terms of all current members of the Company's board of directors expired. All of the four (4) nominees for director were elected to serve until the next annual meeting of stockholders or until their respective successors have been duly elected and qualified, or until such director's earlier resignation, removal or death. The result of the votes to elect the four (4) directors were as follows:
| Directors | For | Withhold |
Broker Non-Votes |
|||||||||
| Wenzhao "Daniel" Lu | 1,141,805 | 359,185 | 2,863,700 | |||||||||
| Lourdes Felix | 1,411,624 | 89,366 | 2,863,700 | |||||||||
| Steven A. Sanders | 1,435,430 | 65,560 | 2,863,700 | |||||||||
| Michael Mathews | 1,440,611 | 60,379 | 2,863,700 | |||||||||